Cargando…
Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco
BACKGROUND: Opioid overdose is a leading cause of death in persons experiencing homelessness (PEH), despite effective medications for opioid use disorder (OUD). In 2016, the San Francisco Street Medicine Team piloted a low barrier buprenorphine program with the primary goal of engaging and retaining...
Autores principales: | Carter, Jamie, Zevin, Barry, Lum, Paula J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501460/ https://www.ncbi.nlm.nih.gov/pubmed/31060600 http://dx.doi.org/10.1186/s13722-019-0149-1 |
Ejemplares similares
-
Mortality Among People Experiencing Homelessness in San Francisco During the COVID-19 Pandemic
por: Cawley, Caroline, et al.
Publicado: (2022) -
Care and Complexity in Emergency Housing: an Examination of the COVID-19 Shelter-in-Place (SIP) Hotel Program to House People Experiencing Homelessness in San Francisco
por: Abbs, Elizabeth, et al.
Publicado: (2023) -
Patient and provider perspectives on barriers and facilitators to
reproductive healthcare access for women experiencing homelessness with
substance use disorders in San Francisco
por: Schmidt, Christina N, et al.
Publicado: (2023) -
Unmet health needs and barriers to health care among people experiencing homelessness in San Francisco’s Mission District: a qualitative study
por: Thorndike, Anna L., et al.
Publicado: (2022) -
LB9. Rising High Rate of Invasive Group A Streptococcus Infections Among Persons Experiencing Homelessness in San Francisco, 2010–2017
por: Scheuer, Tara, et al.
Publicado: (2018)